Dialpha   Report issue

For profit
Founded: Clapiers France (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2013
NCT02074423
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now